PRLD
Prelude Therapeutics IncorporatedstockNASDAQ
Market OpenNov 19, 2026 3:59:05 PM EST
3.26USD-1.364%(-0.04)176,821
PRLD Financials
In Q3 FY 2026 (ended ), Prelude Therapeutics Incorporated (PRLD) reported revenue of $5.65M, net income of −$12.54M, operating cash flow of −$13.78M, and assets of $175.49M (filed ).
Loading financial statements…